250TiP HER2-positive and HER2-low breast cancer patients in the ACE-Pan tumor-01 study: Phase I study evaluating ARX788 as monotherapy in advanced solid tumors with HER2 expression or mutation
Title:
250TiP HER2-positive and HER2-low breast cancer patients in the ACE-Pan tumor-01 study: Phase I study evaluating ARX788 as monotherapy in advanced solid tumors with HER2 expression or mutation
Author:
Lu, J. Budd, G.T. Frentzas, S. Park, H. Shannon, C. Rugo, H.S. O'Shaughnessy, J. Demichele, A. Tolaney, S.M. Eek, R.W. McCartney, A. Cuff, K. Esserman, L. Alika, A. Xu, D. Li, M. Le, T. L'Heureux, D.Z. Yan, J. Hurvitz, S.A.